The biochemical basis of Parkinson's disease: The role of catecholamine o-quinones: A review-discussion

Neurotoxicity Research

Volumn 4, Issue 1, 2002, Pages 77-81

  Smythies, John ^a   De Iuliis, Angela ^a   Zanatta, Lucia ^a   Galzigna, Lauro ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Catecholamine o quinones; Glutathione; Neuromelanin; Parkinson's disease; Reactive oxygen species

Indexed keywords

CATECHOLAMINE; CATECHOLAMINE DERIVATIVE; CATECHOLAMINE O QUINOLONE DERIVATIVE; DOPAMINE; GLUTATHIONE TRANSFERASE; NEUROMELANIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CATECHOLAMINE METABOLISM; CELL DEATH; CONTROLLED STUDY; DETOXIFICATION; HUMAN; HYPOTHESIS; MITOCHONDRION; OXIDATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0036211976     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1080/10298420290007655     Document Type: Article

References (45)

1. "Glutathione transferases catalyze the detoxification of oxidized metabolites (OQs) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes"
2. "The molecular mechanism of dopamine-induced apoptosis: Identification and characterization of genes that mediate dopamine toxicity."
3. "L-DOPA cytotoxicity to PC12 cells in culture is via its autooxidation"
4. "Dopamine neurotoxicity: Inhibition of mitochondrial respiration"
5. "Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species"
6. "Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease"
7. "The parkinsonian neurotoxin MPP+ opens the mitochondrial pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism"
8. "Increased dopamine peroxidation in post-mortem Parkinsonian brains,"
9. "Glutathione homeostasis linked to the vesicular storage of dopamine in rat PC12 pheochromocytoma cells"
10. "The apparent autooxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra"
11. Loss of C1 and C3 epinephrine-synthesizing neurons in the medulla oblongata in Parkinson's disease
12. "A rat brain fraction and different purified peroxidases catalyzing the formation of dopaminochrome from dopamine"
13. "Enzymatic dopamine peroxidation in substantia nigra of human brain"
14. "Enzymatic oxidation of dopamine: The role of prostaglandin H synthase"
15. "Understanding cell death in Parkinson's disease"
16. "Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease"
17. "Interaction of serotoninand dopamine-related neurotoxins with "serotonin binding proteins" in bovine frontal cortex"
18. "Interaction of alpha-synuclein and synphilin-1: Effect of Parkinson's disease-associated mutations"
19. "A possible interaction between acetylcholinesterase and dopamine molecules during oxidation of the amine"
20. "Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: Possible endogenous toxin to serotonin neurons"
21. "Striatal dopamine participates in glutamate-induced hydroxyl radical generation"
22. "Cellular distribution of iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases"
23. "Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-κB in rats"
24. "Biochemical investigations of biopsied brain tissue and autopsied organs from patients with pyroglutamic acidemia (5-oxoprolinemia)"
25. "Prostaglandin H synthetase-mediated metabolism of dopamine; implication for Parkinson's disease"
26. "Tumor necrosis factor alpha is toxic to embryonic mesencephalic neurons"
27. "Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibition"
28. "Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: Relevance to Parkinson's disease"
29. The absence of reactive astiocytosis is indicative of a unique inflammatory process in Parkinson's disease
30. "The role of glutathione in dopaminergic neuronal survival"
31. "Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation"
32. "Mitochondrial function in Parkinson's disease"
33. "Regulation of heme oxygenase-1 expression by dopamine in cultures C6 glioma and primary astrocytes"
34. 3 and oxidation of dopamine to aminochrome"
35. "Oxidation chemistry of (-)-norepinephrine in the presence of L-cysteine"
36. "Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: Possible metabolites of relevance to Parkinson's disease"
37. "The cerebral lesions in a patient with generalized glutathione deficiency and pyroglutamic aciduria (5-oxoprolinemia)"
38. "Conjugates of catecholamines with cysteine and GSH in Parkinson's disease; possible mechanisms of formation involving reactive oxygen species"
39. "Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species"
40. "Tyrosinase, the key enzyme in melanin synthesis, is expressed in murine brain"
41. "Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase"
42. "Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase"
43. "Effects of L-cysteine on the oxidation chemistry of dopamine: New reaction pathways of potentiarelevance to idopathic Parkinson's disease"
44. "Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures"